Axim Biotechnologies Inc (AXIM): Hmmm, not sure if that argument applies....

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: Devolution post# 2565

Thursday, 01/06/2022 10:10:02 AM

Thursday, January 06, 2022 10:10:02 AM

Hmmm, not sure if that argument applies.

Keep Last Read

Next 10 Prev Next

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM

Only $200 per official company press release!